1 |
Sreeharsha N, Prasanthi S, Mahalakshmi SVVNS, Goudanavar PS, Naveen NR, Gowthami B, Fattepur S, Meravanige G, Asdaq SMB, Anwer MK, Aldhubiab B, Islam MM, Habeebuddin M, Telsang M, Gharsan MA, Haroun M. Enhancement of Anti-Tumoral Properties of Paclitaxel Nano-Crystals by Conjugation of Folic Acid to Pluronic F127: Formulation Optimization, In Vitro and In Vivo Study. Molecules 2022;27. [PMID: 36432014 DOI: 10.3390/molecules27227914] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
2 |
Li Z, Ma Y, Lin J, Gao Z, Wu S, Li W, Han D, Gong J, Wang J. The polymorph and crystal habit control of dl-methionine assisted by ultrasound. Journal of Crystal Growth 2022;596:126818. [DOI: 10.1016/j.jcrysgro.2022.126818] [Reference Citation Analysis]
|
3 |
Xiang H, Xu S, Li J, Li Y, Xue X, Liu Y, Li J, Miao X. Functional drug nanocrystals for cancer-target delivery. Journal of Drug Delivery Science and Technology 2022;76:103807. [DOI: 10.1016/j.jddst.2022.103807] [Reference Citation Analysis]
|
4 |
Cui F, Liu J, Pang S, Li B. Recent Advance in Tumor Microenvironment-Based Stimuli-Responsive Nanoscale Drug Delivery and Imaging Platform. Front Pharmacol 2022;13:929854. [DOI: 10.3389/fphar.2022.929854] [Reference Citation Analysis]
|
5 |
Ding J, Guo Y. Recent Advances in Chitosan and its Derivatives in Cancer Treatment. Front Pharmacol 2022;13:888740. [DOI: 10.3389/fphar.2022.888740] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|